Antimicrobial Therapeutics Market
Description
Antimicrobial Therapeutics Market, By Drug Class (Antibacterials, Antivirals, Antifungals, Antiparasitics), By Route of Administration (Oral, Topical, Injectable, Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections (UTIs), Skin and Soft Tissue nfections, Sexually Transmitted Infections (STIs), Gastrointestinal Infections, Central Nervous System Infections, Others), By Spectrum of Activity (Broad-spectrum, Narrow-spectrum), By End-user (Hospitals and Clinics, Homecare, Research Institutes), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Antimicrobial therapeutics are medicines that kill or make it harder for bacteria to grow and multiply in people or animals. They are often used to treat serious infections, such as pneumonia or bloodstream infections (BSIs). Antibiotics can be taken by mouth in the form of pills, tablets, or liquids. They can also be injected or given directly into the bloodstream (IV) for more severe infections. They can also be applied to the skin as a cream, spray, or ointment. When used incorrectly, antibiotics can cause serious side effects and lead to resistant microorganisms. This resistance makes it harder to treat infections with the same medicine or even other medicines that are effective against them.
Market Dynamics:
Increased global demand for these antibiotics, particularly in developing countries is expected to propel growth of the global antimicrobial therapeutics market over the forecast period. Moreover, several bacterial infections are resistant to existing medicines. This has led to the development of newer antimicrobial therapeutics, which are expected to drive market growth over the forecast period.
However, growing antimicrobial resistance is a major factor expected to hamper growth of the global antimicrobial therapeutics market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global antimicrobial therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global antimicrobial therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc., Merck & Co., Inc., Novartis AG, Roche Holding AG, AstraZeneca plc., Sanofi SA, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., AbbVie Inc., Allergan plc., and Mylan N.V.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global antimicrobial therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antimicrobial therapeutics market
Detailed Segmentation:
Global Antimicrobial Therapeutics Market, By Drug Class:
Antibacterials
Antivirals
Antifungals
Antiparasitics
Global Antimicrobial Therapeutics Market, By Route of Administration:
Oral
Topical
Injectable
Others
Global Antimicrobial Therapeutics Market, By Disease Indication:
Respiratory Infections
Urinary Tract Infections (UTIs)
Skin and Soft Tissue Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
Global Antimicrobial Therapeutics Market, By Spectrum of Activity:
Broad-spectrum
Narrow-spectrum
Global Antimicrobial Therapeutics Market, By End-user:
Hospitals and Clinics
Homecare
Research Institutes
Global Antimicrobial Therapeutics Market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profile:
Pfizer Inc.
Johnson & Johnson
GlaxoSmithKline plc
Merck & Co., Inc.
Novartis AG
Roche Holding AG
AstraZeneca plc
Sanofi SA
Bayer AG
Bristol Myers Squibb Company
Eli Lilly and Company
Gilead Sciences, Inc.
AbbVie Inc.
Allergan plc
Mylan N.V.
Table of Contents
165 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Disease Indication
- Market Snapshot, By Spectrum of Activity
- Market Snapshot, By End User
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increased global demand for these antibiotics
- Increasing incidence of infectious diseases
- Restraints
- Growing antimicrobial resistance
- Opportunities
- A rise in geriatric population
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Antimicrobial Therapeutics Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Antimicrobial Therapeutics Market , By Drug Class, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 – 2030
- Segment Trends
- Antibacterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Antifungals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Antiparasitics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 6. Antimicrobial Therapeutics Market , By Route of Administration, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023– 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 7. Antimicrobial Therapeutics Market , By Disease Indication, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023– 2030
- Segment Trends
- Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Urinary Tract Infections (UTIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Skin and Soft Tissue Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Sexually Transmitted Infections (STIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Gastrointestinal Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Central Nervous System Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 8. Antimicrobial Therapeutics Market , By Spectrum of Activity, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023– 2030
- Segment Trends
- Broad-spectrum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Narrow-spectrum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 9. Antimicrobial Therapeutics Market , By End User, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023– 2030
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Homecare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- 10. Antimicrobial Therapeutics Market , By Region, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2023–2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- 11. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Novartis AG
- Roche Holding AG
- AstraZeneca plc.
- Sanofi SA
- Bayer AG
- Bristol Myers Squibb Company
- Analyst Views
- 12. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on “Antimicrobial Therapeutics Market” - Global forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
